Management of acquired resistance to EGFR kinase inhibitors in advanced NSCLC

Benzer Materyaller

• New Strategies in Overcoming Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer
  Yazar:: Oxnard, Geoffrey R., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
  Yazar:: Goldberg, Sarah B., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC.
  Yazar:: Becker, Jeffrey H., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation
  Yazar:: Oxnard, Geoffrey R., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors()
  Yazar:: Nishino, Mizuki, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)